ENTITY
Voronoi

Voronoi (310210 KS)

14
Analysis
Health Care • South Korea
Voronoi, Inc. operates as a drugs development company. The Company develops and manufactures kinase inhibitor and other new drugs. Voronoi provides services in Korea.
more
•29 Oct 2023 05:19

Index Rebalance & ETF Flow Recap: KS200, KQ150, Yuanta Div+, LIT, HSCI, IDX, Japan Positioning

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
1k Views
Share
•24 Oct 2023 05:50

KOSDAQ150 Index Rebalance Preview: Big Sell Off Among Potential Inclusions as Momentum Fades

With momentum fading in Korea, the selloff has hit the potential adds to the KOSDAQ150 especially hard. There could be a few constituent changes...

Logo
810 Views
Share
bullish•Lasertec Corp
•10 Sep 2023 06:30

Index Rebalance & ETF Flow Recap: NKY, ASX, CSI300, KOSDAQ150, Yuanta ETFs, MVA, MVW, SMH

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
783 Views
Share
bullish•Lunit
•04 Sep 2023 06:10

KOSDAQ150 Index Rebalance Preview: Strong Momentum Leads to Outperformance

There could be 14 changes for the KOSDAQ150 in Dec. There could be changes even prior to Dec due to delistings/section transfers. Momentum in Korea...

Logo
744 Views
Share
bullish•HDFC Bank
•02 Jul 2023 06:09

Index Rebalance & ETF Flow Recap: KQ150, LQ45, PCOMP, HDFC/HDFCB, Delta Electronics, Redox IPO, AMFI

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
606 Views
Share
x